首页|载多柔比星双介孔二氧化硅纳米球的表征及体外抗癌研究

载多柔比星双介孔二氧化硅纳米球的表征及体外抗癌研究

Characterization and in Vitro Anticancer Ability of Doxorubicin Loaded Bimodal Mesoporous Silica Nanospheres

扫码查看
目的 制备载多柔比星(doxorubicin,DOX)的双介孔二氧化硅纳米球(bimodal mesoporous silica nanospheres,BMSNs),并评估其体外吸附/脱附特性和对肿瘤细胞增殖的抑制作用.方法 通过溶胶-凝胶法和溶剂热处理途径合成BMSNs;采用扫描电镜、比表面积及孔隙度分析仪、傅里叶变换红外光谱仪、紫外-可见光谱仪等方法对BMSNs进行分析和表征;采用间歇式吸附实验考察BMSNs对DOX的吸附/脱附特性;采用CCK8法检测载DOX双介孔二氧化硅纳米球BMSNs-DOX对人乳腺癌细胞MCF-7和人肺癌细胞A549增殖抑制作用.结果 BMSNs对DOX吸附/脱附能力明显优于典型均匀介孔二氧化硅MCM-41.在pH=7.0时,BMSNs对DOX的吸附量高达91.7 μmol·g-1(即载药量5.32%),是MCM-41吸附量的1.6倍.在pH=5.0缓冲溶液中,BMSNs-DOX对DOX分子的脱附(释放)效率可达约96%,脱附时间仅需约30 min.与MCM-41-DOX和DOX相比,BMSNs-DOX对人乳腺癌细胞MCF-7和人肺癌细胞A549增殖抑制作用更强,在4 μg·mL-1质量浓度时,癌细胞存活率仅为23.67%和15.79%.结论 相比于MCM-41,BMSNs能更快、更多地对癌症细胞释放抗癌药物DOX,BMSNs-DOX对MCF-7细胞和A549细胞有较强的杀伤作用,是一种具有潜在应用价值的新型给药系统.
OBJECTIVE To prepare bimodal mesoporous silica nanospheres loaded with doxorubicin,and evaluate their adsorp-tion/desorption properties and proliferation inhibition effects on cancer cells.METHODS bimodal mesoporous silica nanospheres(BMSNs)were prepared using sol-gel method and thermal treatment.The nanospheres were analyzed and characterized using scanning electron microscopy,specific surface area and porosity analyzer,Fourier transform infrared spectroscopy,and UV-VIS spectrometer.The adsorption/desorption characteristics of DOX by BMSNs were investigated by adsorption experiment.The proliferation inhibition effects of BMSNs-DOX on MCF-7 cells and A549 cells were detected using CCK8 method.RESULTS Compared with mesoporous MCM-41,which has typical uniform mesopores,BMSNs could provide more favorable matter diffusion and adsorption capacity towards DOX due to their more expansive pore structure.At pH=7.0,BMSNs exhibited a high adsorption capacity for DOX of 91.7 μmol·g-1(equivalent to a drug loading capacity of 5.32%),which was 1.6 times higher than that of MCM-41.In pH=5.0 buffer solution,BMSNs-DOX desorbed(released)DOX molecules with an efficiency of about 96%,in just 30 minutes.BMSNs-DOX exhibited a stronger inhibitory effect than MCM-41-DOX and DOX.At a concentration of 4 μg·mL-1,the survival rate of MCF-7 cells and A549 cells was only 23.67%and 15.79%respectively.CONCLUSION Compared with MCM-41,BMSNs is expected to release DOX to cancer cells more efficiently.BMSNs-DOX exhibits a significant inhibitory effect on MCF-7 cells and A549 cells,suggesting its poten-tial as a drug carrier to enhance the cytotoxicity of chemotherapy drugs on cancer cells.

bimodal mesoporous silica nanospheresdoxorubicinadsorptiondesorptionanticancer

聂晓娅、张小娟、张艳、葛少兵、胡清伟

展开 >

重庆医药高等专科学校,重庆 401331

重庆市药物制剂工程技术研究中心,重庆 401331

西北工业大学,西安 710072

双介孔二氧化硅纳米球 多柔比星 吸附 脱附 抗癌

重庆市自然科学基金面上项目资助重庆市教委科学技术研究青年项目资助重庆医药高等专科学校科研教研项目资助

cstc2020jcyjmsxmX0627KJQN201902803CQYGZJG2003

2024

中国药学杂志
中国药学会

中国药学杂志

CSTPCD北大核心
影响因子:0.957
ISSN:1001-2494
年,卷(期):2024.59(14)
  • 1